A type-II positive allosteric modulator of α7 nAChRs reduces brain injury and improves neurological function after focal cerebral ischemia in rats.
about
Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disordersRole of α7 nicotinic receptor in the immune system and intracellular signaling pathwaysNew Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from Nicotine.Alpha-7 nicotinic acetylcholine receptor agonist treatment reduces neuroinflammation, oxidative stress, and brain injury in mice with ischemic stroke and bone fractureHigh therapeutic potential of positive allosteric modulation of α7 nAChRs in a rat model of traumatic brain injury: proof-of-conceptAlterations in Cholinergic Pathways and Therapeutic Strategies Targeting Cholinergic System after Traumatic Brain Injury.The Antinociceptive and Antiinflammatory Properties of 3-furan-2-yl-N-p-tolyl-acrylamide, a Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptors in MiceThe therapeutic promise of positive allosteric modulation of nicotinic receptors.Understanding the Bases of Function and Modulation of α7 Nicotinic Receptors: Implications for Drug Discovery.Targeting α7 nicotinic acetylcholine receptors: a future potential for neuroprotection from traumatic brain injury.Cholinergic modulation of the immune system presents new approaches for treating inflammation.Insights into nicotinic receptor signaling in nicotine addiction: Implications for prevention and treatment.Mechanisms of neuroprotection against ischemic insult by stress-inducible phosphoprotein-1/prion protein complex.Boosting Endogenous Resistance of Brain to Ischemia.Recombinant PEP-1-SOD1 improves functional recovery after neural stem cell transplantation in rats with traumatic brain injury.
P2860
Q26765419-19E32697-C3A4-4FE3-9E1A-1F929E631969Q26773176-C4474C79-E17E-4C65-9901-E7CF21E8A266Q34426718-5C4E7F35-7DB7-473B-ADB4-FC4CEA1C8904Q34459091-0F53243E-0C44-4D72-B359-F98AE2B1582EQ35155905-DDDD21EE-A530-44FD-AA0E-37FD3AAC4405Q36830205-9AFE611F-3376-4439-83DE-F1528BCF98FEQ36842788-0FAAD1D5-A451-42B8-BEFC-987C2AA4D908Q37695734-CEE352B3-BD5C-40A4-9E08-759BE74248B3Q38837028-0D937548-3F1A-4B5B-A63F-5C1A6C64BDE1Q38929250-60CB72A6-629C-4383-93FD-711C29EBC2EFQ39320915-A5F20C7F-D49E-4118-AFCB-48745B21836EQ40111690-FB2B6ECA-B9E8-4925-B0BB-7D718D6B5B7DQ47267007-41B63753-D6ED-4834-B83F-574FF97B475DQ48881700-E6EB5ED2-F76A-4BE1-A314-E1789E3CFB5FQ55360436-74FF435F-F712-45FD-A95D-F625E795EA24
P2860
A type-II positive allosteric modulator of α7 nAChRs reduces brain injury and improves neurological function after focal cerebral ischemia in rats.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A type-II positive allosteric ...... cal cerebral ischemia in rats.
@ast
A type-II positive allosteric ...... cal cerebral ischemia in rats.
@en
A type-II positive allosteric ...... cal cerebral ischemia in rats.
@nl
type
label
A type-II positive allosteric ...... cal cerebral ischemia in rats.
@ast
A type-II positive allosteric ...... cal cerebral ischemia in rats.
@en
A type-II positive allosteric ...... cal cerebral ischemia in rats.
@nl
prefLabel
A type-II positive allosteric ...... cal cerebral ischemia in rats.
@ast
A type-II positive allosteric ...... cal cerebral ischemia in rats.
@en
A type-II positive allosteric ...... cal cerebral ischemia in rats.
@nl
P2093
P2860
P1433
P1476
A type-II positive allosteric ...... cal cerebral ischemia in rats.
@en
P2093
Kunlin Jin
Victor V Uteshev
P2860
P304
P356
10.1371/JOURNAL.PONE.0073581
P407
P577
2013-08-09T00:00:00Z